OVA conjugated Leukemia inhibitory factor(LIF)

  • Catalog number
    CPA085Po21
  • Price
    Please ask
  • Size
    200ug
  • Source
    Protein conjugation
  • Predicted Molecular Mass KD
    NA
  • Accurate Molecular Mass KD
    NA
  • Organism species
    Sus scrofa; Porcine (Pig)
  • Item Name
    Leukemia Inhibitory Factor
  • Alternative Names
    CDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
  • Research Area
    Cytokine;Tumor immunity;Infection immunity;Neuro science;Bone metabolism;
  • Buffer Formulation
    PBS, pH7.4.
  • Traits
    Freeze-dried powder
  • Purity
    >90%
  • Protein length
    NA
  • Tag
    No tag
  • Expression System
    Protein Conjugation
  • Application
    Immunogen; SDS-PAGE; WB
  • Description
    Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.
  • Gene
    Ovalbumin (abbreviated OVA) is the main protein found in egg white, making up 60-65% of the total protein. Ovalbumin displays sequence and three-dimensional homology to the serpin superfamily, but unlike most serpins it is not a serine protease inhibitor. The function of ovalbumin is unknown, although it is presumed to be a storage protein. OVA is also the best characterized and the first antigen proteins used as a transgene to make transgenic mice. Many different transgenic mouse models have systemic OVA expression driven by the ubiquitously expressed b-actin promoter or tissue-specific OVA expression with insulin promoter to drive the transgene expression, for studying type I diabetes, or in different isoforms, secreted or cell-membrane associated, and more recently as inducible transgene models. These C57BL/6 mice, BALB/c mice models are well characterized, and have contributed to our understanding of immunogenicity and tolerance by the OVA model.
  • Gene target
  • Gene symbol
    LIF-AS1, LIF-AS2, LIF
  • Short name
    OVA conjugated Leukemia inhibitory factor(LIF)
  • Technique
    antibody Conjugates
  • Host
    chemical synthesis
  • Species
    Sus scrofa; Porcine (Pig)
  • Alternative name
    OVA coupled Leukemia inhibitory factor(leukemia inhibitory factor)
  • Alternative to gene target
    leukemia inhibitory factor, CDF and DIA and HILDA and MLPLI, LIF and IDBG-3968 and ENSG00000128342 and 3976, growth factor activity, Extracellular, Lif and IDBG-142317 and ENSMUSG00000034394 and 16878, LIF and IDBG-636335 and ENSBTAG00000007424 and 280840
  • Virus
    leukemia
Gene info
Gene info
  • Identity
  • Gene
  • Long gene name
    LIF antisense RNA 2
  • Locus
  • Discovery year
    2020-10-07
  • Entrez gene record
  • RefSeq identity
  • Classification
    • Antisense RNAs
Gene info
MeSH Data
  • Name
  • Concept
    Scope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
  • Tree numbers
    • C04.557.337.372
    • C04.619.531
    • E05.598.500.496.500
  • Qualifiers
    diagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery
Similar products
Filters
Contact
Chat with gentaur.com employee